Streptococcus dysgalactiae spp. dysgalactiae is an important causative agent of bovine mastitis worldwide. Lactoferrin is an innate immune protein that is associated with many functions including immunomodulatory, antiproliferative and antimicrobial properties. This study aimed to investigate the interactions between lactoferrin and a clinical bovine mastitis isolate, S. dysgalactiae spp. dysgalactiae DPC5345. Initially a deliberate in vivo bovine intramammary challenge was performed with S. dysgalactiae DPC5345. Results demonstrated a significant difference in lactoferrin mRNA levels in milk cells between the control and infused quarters 7 hours post infusion. Milk lactoferrin levels in the S. dysgalactiae DPC5345 infused quarters were significantly increased compared to control quarters at 48 h post infusion. In vitro studies demonstrated that lactoferrin had a bacteriostatic effect on the growth of S. dysgalactiae DPC5345 and significantly decreased the ability of the bacteria to internalise into HC-11 mammary epithelial cells. Confocal microscopy images of HC-11 cells exposed to S. dysgalactiae and lactoferrin further supported this effect by demonstrating reduced invasion of bacteria to HC-11 cells. The combined data suggests that a bovine immune response to S. dysgalactiae infection includes a significant increase in lactoferrin expression in vivo and, based on in vitro data, lactoferrin limits mammary cell invasion of this pathogen by binding to the bacteria and preventing its adherence.
INTRODUCTION
Bovine mastitis infection has serious deleterious effects on milk quality and is a significant limiting factor to profitable dairy farming worldwide (Bar et al., 2008; Berry and Amber, 2005; Kossaibati and Esslemon, 1997) . Mastitis infection occurs when a bacterial pathogen gains entry to the mammary gland via the teat canal. Infection is then established through bacterial evasion of both the anatomical and humoral defence mechanisms of the mammary gland (Zhao and Lacasse, 2008) Streptococcus dysgalactiae subspecies dysgalactiae (S. dysgalactiae) has been described as both a contagious mastitis pathogen (Fox et al., 1993) and an environmental pathogen (Calvinho et al., 1998) and has been detected in clinical and subclinical bovine mastitis cases (Girma et al., 2012; Bitew et al., 2010; Piepers et al., 2007; Barrett et al., 2005) . Traditional mastitis control programmes have had limited effects on reducing the incidence of S. dysgalactiae infections due to the adaptability of the bacteria (Bolton et al., 2004) . S. dysgalactiae have cell-associated and extracellular virulence factors which contribute to the establishment and persistence of intramammary infection (IMI) . In vitro studies have demonstrated that the bacteria can adhere to mammary epithelial cells and internalise (Calvinho and Oliver, 1998a; Almeida and Oliver, 1995) . Once internalised within the cell, the bacteria can survive by evading the action of antimicrobial drugs and host immune defence components.
Conventional treatment for mastitis involves the administration of antibiotics.
Antimicrobial resistance in mastitis pathogens
is not yet considered a clinically relevant issue (Oliver and Murinda, 2012; Pyorala, 2009) , however, the intensive use of antibiotics can lead to the development of resistant strains (Hendriksen, 2008) . In addition, dairy cows produce milk for human consumption, therefore, antibiotic traces in milk is a public health concern.
The development of effective, alternative approaches to control and/or treat mastitis would be of significant benefit to the dairy industry. One approach would be to manipulate and enhance natural host defence mechanisms. However, different pathogens display distinct invasion and pathogenic mechanisms (Chaneton et al., 2008) . Detailed knowledge of the specific host-pathogen interactions that are required to establish and develop IMI is fundamental to the design of adequate treatment and control policies.
Lactoferrin is an innate immune protein that is predominantly secreted in vivo by neutrophils and specific glandular tissue (Ling and Schryvers, 2006) . Its production is both constitutively and differentially regulated in a tissue-specific manner (Teng et al., 2002) .
Lactoferrin is a multifunctional protein being associated with antibacterial, immunomodulatory, antiadhesive and iron-binding properties (Chierici, 2001; Ueta et al., 2001; Ajello et al., 2002) . It is described as broad spectrum, affecting the growth and proliferation of a variety of gram negative and gram positive pathogens (Adlerova et al., 2008) with both bacteriostatic and bacteriocidal effects (Kutila et al., 2003) . Bovine milk lactoferrin levels change over the course of lactation, as well as in response to mammary gland infections (Kawai et al., 1999) . Bahar et al (2011) also demonstrated that genetic polymorphisms within the lactoferrin gene promoter can affect milk lactoferrin levels.
In general, streptococcal species are considered more resistant to the antibacterial effects of lactoferrin (Fang et al., 2000) . This may be due to the fact that streptococcal species have low iron requirements (Weinberg, 1978) or it may be due to their ability to extract the metal from iron-containing host proteins (Ruiguang et al., 2009) . Indeed lactoferrin binding proteins have been found in several streptococcal species, including S. uberis, S. agalactiae and S. dysgalactiae (Park et al., 2002a) , suggesting a role for lactoferrin in relation to streptococcal infections, which may have important implications for the pathogenesis of IMI. Patel et al (2009) demonstrated that S. uberis isolates bind lactoferrin via a surface-exposed adhesion molecule which they defined as the S. uberis adhesion molecule (SUAM). These in vitro studies suggest that S. uberis hijacks lactoferrin to act as a bridging molecule between the bacterial cell surface and lactoferrin receptors on host mammary epithelial cells. This allows S. uberis to adhere, invade and establish within bovine mammary epithelial cells.
Interestingly in vivo bovine studies by Chaneton et al (2008) demonstrated that in subclinical cases of mastitis, bovine milk lactoferrin levels significantly increased in S. uberis infected quarters (P<0.001) when compared to uninfected quarters. It was hypothesized that S. uberis isolates were resistant to bovine lactoferrin activity and high levels of the lactoferrin in milk promoted the pathogenesis of S. uberis in vivo. Other mastitis-causing bacteria, including S. aureus, S. dysgalactiae and coagulase negative staphylococcus were not associated with a significant increase in bovine milk lactoferrin levels in these subclinical cases. (Almeida et al., 2006) . These studies suggest that lactoferrin secretion in the bovine mammary gland is a pathogen-specific response. Park et al (2002b) , using SDS-PAGE and western blotting, confirmed the expression of two lactoferrin binding proteins in S. dysgalactiae isolates (52-and 74KDa) and three lactoferrin binding proteins in S. agalactiae isolates (52-,70-and 110 KDa). However, studies on the specific interaction between these streptococcal species and lactoferrin is limited and thus the role of lactoferrin binding proteins in the pathogenesis of S. dysgalactiae and S. agalactiae intramammary infections must still be elucidated.
The aim of this study was to investigate the interaction in vitro between lactoferrin and S. dysgalactiae in order to identify whether this milk protein combats or promotes S. dysgalactiae infection. In vivo studies were conducted to quantify the changes in milk lactoferrin levels over the course of a mammary gland infection caused by a deliberate challenge with S. dysgalactiae
MATERIALS AND METHODS

Bacterial Culture
Streptococcus. dysgalactiae subspecies dysgalactiae (S. dysgalactiae) DPC 5345 was isolated on a Teagasc farm from a clinical mastitis case. The isolate was confirmed as streptococcus by selective plating on blood-esculin agar plates and characterised to species level by 16s PCR (Riffon et al, 2001) . A 2 % inoculum of S. dysgalactiae DPC 5345 yielded 10 8 colony forming units (CFU) /ml when cultured overnight at 37 o C in tryptic soy (TS) broth (Difco Laboratories, Detroit, USA).
Animal selection
Five Holstein-Friesian cows were selected, based on their health status, for a deliberate intramammary challenge with S. dysgalactiae DPC 5345. These were spring-calving cows that were based on Teagasc research stations in the south of Ireland. Health status was determined using visual examination of milk and udders and milk somatic cell counts (SCC), with a count of <200,000 cells/ml considered as healthy. In addition, no pathogens were isolated from the quarter milks of test animals for 7 consecutive days prior to the challenge. 
Intramammary challenge
The intramammary challenge with S. dysgalactiae DPC5345 was performed according to a procedure described by Beecher et al. (2012) . Briefly, overnight cultures of S. dysgalactiae DPC5345 were diluted with maximum recovery diluent (MRD; Oxoid Ireland, Dublin, Ireland) to prepare 2 ml suspensions at 2500 CFU dysgalactiae. This bacterial count was chosen as preliminary trials indicated that 2500 CFU is sufficient to cause infection (Beecher et al., 2012) . Immediately after morning milking, one quarter from each animal was infused with the bacterial suspension into the teat sinus via the streak canal. The contra-lateral quarter was infused with 2 ml of MRD only and served as the internal control. Total quarter milk samples (or up to 2 L volume) were collected from each infused and control quarter immediately prior to infusion and at 7 h, 24 h, 48 h, 7 days and 14 days post infusion. From each milk sample 100 L was plated onto esculin blood agar plates (Thermo Scientific, Wilmington, DE, USA) to monitor bacterial infection. Milk somatic cell counts were also determined using a Somacount 300  somatic cell counter (Bently instruments Inc., Chaska, MN, USA). For animal welfare purposes, intramammary-challenged cows received antibiotic treatment (Leo Yellow; Boehringer Ingelheim, Berkshire, UK) as soon as clinical signs of infection were observed.
RNA extraction from somatic cells
To isolate RNA from milk somatic cells, 1 ml 0.5 M EDTA (Sigma-Aldrich, Ireland) was added to each litre of milk and the samples were then centrifuged at 1500 x g for 30 min at 4 C. The fat layer was removed and cell pellets were washed twice with PBS (pH 7.4) containing 0.5 mM EDTA. Pellets were then re-suspended in 1 ml TriPure isolation reagent (Roche Diagnostics, East Sussex, UK) and RNA was extracted according to the manufacturers' instructions. All RNA was quality assessed through visualisation on glyoxyl gels (1.5 %) (Ambion, Applied Biosystems, Foster City, USA) and quantified using the Nanodrop 1000 (Thermo Scientific, Wilmington, DE, USA).
Real-time PCR
One microgram of RNA was converted to cDNA using the QuantiTect ® Reverse
Transcription Kit (Qiagen, Crawley, West Sussex, UK), and 1 μl cDNA was used per subsequent real-time PCR reaction. Primers designed by Li et al. (2009) were used to detect and amplify the lactoferrin gene (forward primer 5'-AAACAAGCATCGGGATTCCAG-3'
and reverse primer 5'-ACAATGCAGTCTTCCGTGGTG-3'). Quantitative analysis was performed in a LightCycler 480 instrument (Roche Diagnostics, East Sussex, UK) using a dilution series of external plasmid DNA standards (10 9 -10 2 copies/µl) (Pfaffl, 2001) . 
Protein quantitation by ELISA
Milk lactoferrin was quantitated using an ELISA kit (Bethyl Laboratories Inc., Montgomery
Texas, USA) and according to the manufacturers' instructions. Milk samples were diluted 1:2000 and standard curves generated for each sample set. Minimum detection levels for lactoferrin were 7.8 ng/ml lactoferrin concentrations were quantified by interpolating the absorbance values from the standard curve. Test samples were analysed by ELISA in duplicate and the analysis performed on 2 separate occasions.
Antibacterial assay
The antibacterial activity of a commercial bovine native lactoferrin protein (#L9507, SigmaAldrich, Ireland) was tested against S. dysgalactiae DPC5345. For this, an overnight culture of S. dysgalactiae DPC 5345 was diluted to 10 7 CFU/ml in TS broth (Oxoid, Ireland) and 40 μl of the culture added to each test well in a 96 well plate. The lactoferrin protein was initially prepared at a stock of 20 mg/ml by diluting in distilled water and sterile filtered using 0.45 m filters (Millipore, UK). The final concentrations of lactoferrin tested were 0.02, 0.2, 2.0, 5.0 and 10.0 mg/ml. Plates were incubated at 37 C and growth curves generated by measuring absorbance at 620 nm every hour for 24 h using a spectrophotometer. Assays were performed in triplicate.
Cell line and tissue culture
The HC-11 murine mammary epithelial cell line used in this study was kindly donated by Dr.
Wolfgang Doppler (Innsbruck Medical University, Austria). Cells were grown and maintained in RPMI 1640 media (Sigma-Aldrich, Ireland) supplemented with 4 mM LGlutamine (Sigma-Aldrich), 10 % foetal bovine serum (FBS; Sigma-Aldrich, Ireland), 5 μg/ml insulin (Sigma-Aldrich), 10 ng/ml epidermal growth factor (EGF, Sigma-Aldrich, Ireland), 100 U/ml penicillin (Sigma-Aldrich, Ireland) and 100 μg/ml streptomycin (SigmaAldrich, Ireland).
Invasion assays with S. dysgalactiae
Invasion assays were performed on the same day, in triplicate, as per Calvinho and Oliver (1998b) with some minor modifications. Briefly, HC-11 cells were seeded into 24-well plates at a density of 1 x 10 5 cells/well and grown to confluency in antibiotic-free RMPI 1640 supplemented media. An overnight culture of S. dysgalactiae DPC 5345 was washed 3 times in phosphate buffered saline (PBS; Sigma-Aldrich, Ireland) and re-suspended in antibioticfree RPMI 1640 supplemented media, to a final concentration of ~1 x 10 7 CFU/ml. On the day of the assay, HC-11 cell monolayers were washed 3 times in PBS and 1 ml aliquots of the bacterial culture (1 x 10 7 CFU/ml) was added to each test well. Sterile-filtered solutions of lactoferrin, prepared with antibiotic-free RPMI 1640 supplemented media, were added (1 ml) to test wells such that the final concentrations tested were 0.01, 0.1, 1.0 and 2.0 mg/ml lactoferrin. Control wells contained S. dysgalactiae DPC5345 culture and 1 ml PBS only.
Plates were incubated at 37C, 5% CO2 for 2 h. Supernatants were aspirated off into sterile 1.5 ml eppendorf tubes and diluted 10-fold for bacterial counting. Culture wells were then washed 3 times with PBS (1 ml), followed by incubation for a further 2 h in RPMI 1640
supplemented media containing 5 ug/ml penicillin and 100 U/ml gentamicin. Following the second incubation, media was removed and cells were washed 3 times with 1 ml PBS. HC-11 cells were then lysed by adding 0.25 % trypsin (Sigma-Aldrich, Ireland) and 0.025 % Triton X-100 (Sigma-Aldrich, Ireland) and the lysates collected into sterile 1.5 ml eppendorfs and vigorously vortexed for 15 seconds. Cell lysates were serially diluted 10-fold (10 -1 to 10 -4 ) and 0.1 ml dilutions plated onto TS agar plates for bacterial counting and incubated at 37C overnight. Adherence, at lactoferrin concentrations tested, was expressed as (CFU/ml in the cell lysates) / (CFU/ml in the supernatant) X 10,000 (Fang et al., 2000) . Each lactoferrin concentration was tested in duplicate and the assays performed on four separate occasions. 1 ml antibiotic-free RPMI 1640 supplemented media mixed with 1 ml bacterial culture (~10 7 CFU/ml). All cell culture plates were incubated for 2 h at 37 C, 5 % CO2 and then the media removed before washing twice with PBS (5 ml).
Confocal Scanning Microscopy and
Before imaging, cells were stained with the Live/Dead BacLight Bacterial Viability Kit solution (Molecular Probes, Inc., Eugene, OR, USA). An argon ion laser was used to generate the 488 line used for excitation. Imaging was performed using a Leica TCS SP5
confocal laser scanning microscope (Leica Microsystems, Heildelberg GmbH, Mannheim, Germany) using a 63 x oil immersion objective (AN = 1.4). RGB colour images (24 bit), 512
x 512 pixels in size, were acquired. A minimum of 4 z-stacks were taken per sample with representative cross sections of micrographs shown.
Statistical Analysis
For statistical analysis, gene expression data was transformed by obtaining the natural logarithm. A hierarchical mixed model (PROC MIXED; SAS Version 9.1, SAS Institute Inc., Cary, NC, USA) was used to quantify the effect of treatment (control or infused) on gene expression and the dependent variable was transformed gene expression.. Fixed effects included in the model were time relative to the start of the study, treatment and time by treatment interaction. Where significant (P < 0.05), a covariate, which was the gene expression for the control and infused quarters at time zero, was included as a fixed effect.
Time relative to the start of experiment was included as a repeated effect within the udder quarter, and cow was included as a random effect. Least squares means were extracted from the analysis and differences between the control and infused quarters were considered significant at P < 0.05. With regards to the milk protein secretion data statistical analysis was performed as above, without transformation, as data was normally distributed. As with gene expression data differences between the control and infused quarters were considered significant at P < 0.05.
For the antibacterial assay, a paired Student's T-test was employed to investigate the effect of different lactoferrin concentrations on bacterial growth. The bacteriostatic effect of each concentration tested was considered significantly different from the control at P < 0.05.
A paired Student's T-test was also employed in the invasion assay to identify differences in bacterial counts recovered. The number of bacteria recovered from different experiments were considered significantly different at P < 0.05.
RESULTS
The effect of a deliberate intramammary challenge with S. dysgalactiae on lactoferrin levels in vivo was investigated to determine if the bovine immune response to this mastitis pathogen included alterations to the transcription and/or secretion of this antibacterial protein.
Bacterial growth in infected quarters post intramammary challenge
Following the infusion of experimental quarters with 2500 CFU S. dysgalactiae DPC5345 .
In vivo levels of lactoferrin mRNA and protein following intramammary challenge
To investigate if lactoferrin gene expression and / or lactoferrin protein levels in milk were affected by the deliberate S. dysgalactiae DPC5345 intramammary challenge lactoferrin mRNA and protein levels were measured in the control quarters and the infused quarters at 0, 7, 24 and 48 h post infusion. Control quarters acted as internal controls for each animal.
There was a significant difference (P < 0.05) in lactoferrin mRNA levels between the control and infused quarters at 7 h post infusion (Table 1) with lactoferrin mRNA levels reduced in the infused quarter. At all other time points tested, lactoferrin mRNA levels did not significantly differ between the control and infused quarters (Table 1) . Lactoferrin protein levels were significantly increased (P < 0.05) in infused quarters compared to control quarters at 48 h post infusion (Table 2 )
Antibacterial activity
To investigate the influence of a commercial preparation of bovine lactoferrin on the growth of the S. dysgalactiae culture DPC5345 in a laboratory setting a 24 h growth curve was performed. DPC5345 was cultured in complex media with various concentrations of lactoferrin. Results from the 24 h growth curves demonstrated that lactoferrin had a bacteriostatic effect on S. dysgalactiae DPC5345 (Figure 1 ). At 14 h  0.2 mg/ml lactoferrin had a significant effect on bacterial growth (P < 0.05) when compared to the control (no lactoferrin).
Invasion assay and Confocal Imaging
To examine if lactoferrin influenced the ability of S. dysgalactiae DPC5345 to invade epithelial cells, an invasion assay was performed using the HC-11 murine mammary epithelial cell line. HC-11 cell monolayers were incubated with ~1 x 10 7 CFU/ml of fresh bacterial culture and a range of physiologically relevant concentrations of lactoferrin from 0.01-2.0 mg/ml (Schanbacher et al., 1993) . After 4 h incubation lactoferrin reduced the number of live bacteria in the cell lysate in a dose dependent manner with significant reductions associated with 0.1, 1.0 and 2.0 mg/ml lactoferrin compared to the negative control. At 2 mg/ml of lactoferrin, more than a log fold reduction in the number of internalised bacteria (4.1 log10 CFU/ml) was observed compared to the negative control (5.52 log10 CFU/ml) and 0.01 mg/ml lactoferrin (5.34 log10 CFU/ml (Table 3 ). The adherence index value was calculated by dividing the number of bacterial CFUs in the cell lysate by the number of CFUs in the supernatant and therefore gives an indication of the ability of the bacteria to adhere and internalise into HC-11 cells. In the absence of lactoferrin, the adherence index value was 37.72. With each increasing lactoferrin concentration (0.01, 0.1, 1.0 and 2.0 mg/ml) the adherence index value reduced (32.5, 20.67, 13.54 and 3.35 respectively) in a dose dependent manner (Table 3) , demonstrating decreased internalisation.
This effect was visually confirmed by confocal microscopy (Figure 2 ) which showed that in the absence of lactoferrin viable S. dysgalactiae bacteria internalised into the mammary HC-11 cells (Figures 2A and 2B respectively) . When the Dylight 633 fluorescently labelled lactoferrin (~2 mg/ml) was added to the HC-11 cells, the labelled protein bound to the bacteria at HC-11 cell membrane boundaries ( Figure 2C ) and also to the bacteria that had internalised within the HC-11 cells ( Figure 2D ). These microscopic images indicate that S.
dysgalactiae bacteria and the lactoferrin protein co-localise.
DISCUSSION
A deliberate bovine intramammary challenge with S. dysgalactiae resulted in a significant increase (P < 0.05) in milk lactoferrin protein compared to controls. Follow up in vitro studies demonstrated that lactoferrin is a bacteriostatic agent that interferes with the ability of S. dysgalactiae to adhere and internalise into mammary epithelial cells. Co-localisation images suggest a direct interaction between lactoferrin and S. dysgalactiae cells demonstrating that this bacteria binds to the lactoferrin protein. The combined data indicates that a bovine immune response to S. dysgalactiae infection includes increased milk lactoferrin levels and this immune protein appears to limit mammary cell invasion of this pathogen by binding to the bacteria and reducing host cell adherence.
For some mastitis pathogens it has been shown that lactoferrin promotes the pathogenicity of the bacteria. Patel et al., (2009) demonstrated, in vitro, that lactoferrin served as a molecular bridge for Streptococcus uberis (S. uberis) species, promoting bacterial internalisation into mammary epithelial cells and potentially providing an opportunity for this pathogen to survive against host defence mechanisms. In contrast to this our study indicates that lactoferrin plays a role in preventing infection by S. dysgalactiae species by interfering with bacterial adhesion of the mammary epithelial cell. This has significance with regards to establishing intramammary infections by this pathogen, as adherence is an important stage in the pathogenesis of bovine mastitis (Calvinho et al., 1998) .
The main bacteriostatic effect of lactoferrin is thought to be due to its ironsequestering ability. When iron is depleted from the environment it limits the growth of pathogens . However, streptococcal species have a low iron requirement (Fang et al., 2000) and therefore alternative mechanisms must exist by which lactoferrin is bacteriostatic against streptococci. Park et al (2002a) demonstrated that, similar to S. uberis species, S. dysgalactiae express lactoferrin binding proteins (LFBPs). The existence of these proteins facilitates an interaction between lactoferrin and S. dysgalactiae cells (Park et al 2002b) but the mechanism of the interaction and the physiological effect is unknown. Barboza et al. (2012) demonstrated that the glycan component of lactoferrin plays an essential role in pathogen recognition and inhibits bacterial binding to host epithelial cells.
Other studies have confirmed that when lactoferrin binds with bacterial proteins it is capable of interfering with essential bacterial processes. Ochoa et al (2003) and Gomez et al (2003) have shown that lactoferrin can inhibit the function of type III secretory systems in the gram negative pathogens enteropathogenic E. coli and Shigella flexneri respectively. These secretory systems play a significant role in the adherence and invasion of these gram negative pathogens into mammalian cells. Lactoferrin was shown to inhibit pathogen adherence to host cells via a mechanism that involved proteolytic degradation of essential proteins required for bacterial contact and pore formation . Results from the current study demonstrate that lactoferrin is bacteriostatic against S. dysgalactiae species which could be due to the presence of these LFBPs. Further characterisation of these proteins within S.
dysgalactiae is required and would offer more insight into the mechanism of interaction between this streptococcal species and lactoferrin. This would help further elucidate the role that lactoferrin plays in limiting mastitis infection caused by S. dysgalactiae and could potentially lead to alternative control strategies for mastitis caused by this pathogen.
Although it could be argued that only one strain was examined in the present study, Park et al (2002b) demonstrated that there was no difference in the lactoferrin binding capacity of several S. dysgalactiae species investigated.
Lactoferrin mRNA levels were reduced in the early period of invasion of S.dysgalactiae. Lactoferrin protein levels did not differ within this time period but later, at 48 h post-infusion, there was a statistically significant increase (P<0.05) in the average milk lactoferrin levels from the infused quarters compared to the control quarters. Bovine milk lactoferrin levels are reported in general to be between 20 -200 mg/L (Rainard and Riollet, 2006 ) but levels vary from one animal to another, vary in mammary quarters and as lactation progresses the mean lactoferrin concentration increases (Cheng et al., 2008) . In some cases of mastitis levels also increase (Kawai et al., 1999) . Chaneton et al. (2008) reported that in subclinical bovine mastitis cases, when the individual contribution of each pathogen was investigated, S. dysgalactiae infections were not associated with a significant increase in milk lactoferrin levels. In clinical mastitis cases where there was a significant increase in milk lactoferrin, the causative bacteria was not known. Whether the increase in milk lactoferrin levels observed in this study is biologically significant warrants further investigation.
Mammary epithelial cells not only sense bacterial pathogens but also recruit neutrophils to the site of infection (Rainard and Riollet, 2006; Strandberg et al., 2005) . This boosts the local concentration of lactoferrin protein as it is released from neutrophil secondary granules (Zhao and Lacasse, 2008) . The increased levels of lactoferrin concentration at 48 h post infusion may therefore be as a result of neutrophil recruitment or delayed lactoferrin production from mammary epithelial cells or both.
The results from this study further emphasise that the interaction between the milk protein lactoferrin and bacteria is species-specific. Further studies are required to characterise this interaction and understand the host-pathogen response in S. dysgalactiae infections to pave the way for the development of bacterial targeted mastitis therapies and prophylactics. Table 2 . Lactoferrin protein (µg/mL) in milk from S. dysgalactiae infused quarters compared to control quarters. Values are given as the average data of 5 animals + standard deviation.
(SD = Standard Deviation; NS = Not Significant; P < 0.05 indicates significantly different at that time point; n = number of animals measured at each time point). Table 3 . Effect of lactoferrin concentrations (mg/mL) on adherence and invasion of S. dysgalactiae DPC5345 (CFU/mL) into HC-11 mammary epithelial cells (1 x 10 5 cells/well). Adherence index calculated as (CFU in the cell lysates) / (CFU in the supernatant) X 10,000 (Fang et al., 2000) .  Values given represent mean of replicates (n = 8) (±SEM) of live bacterial recovered (CFU/ml) from HC-11 cell supernatant or cell lysate in the invasion assay. Comparing data within columns a indicates lactoferrin concentration tested had no significant effect on bacterial cell count (CFU/mL) compared to control (no lactoferrin); b indicates lactoferrin concentration tested had significant (P < 0.05) effect on bacterial cell count (CFU/mL) compared to control (no lactoferrin)
